Papers
1
Total Citations
27
H-Index
1
About
Dr. Xuemei Wang is a leading clinical researcher specializing in prostate cancer treatment outcomes and patient quality of life. Her work focuses on comparative effectiveness research, particularly evaluating how different therapeutic modalities—such as brachytherapy and robot-assisted radical prostatectomy—affect patients' functional recovery and well-being. Dr. Wang’s most cited study, a prospective cohort published in 2017 (27 citations), provides critical, patient-centered data comparing quality of life after these two major treatments, helping men make more informed decisions about their care. By rigorously assessing post-treatment urinary, sexual, and bowel function alongside overall QoL, her research bridges the gap between clinical efficacy and real-world patient experience. Dr. Wang’s contributions are vital for shared decision-making in oncology, ensuring that treatment choices align with patients’ values and priorities. Her work continues to shape evidence-based guidelines and improve survivorship care for men with prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1